Dr. Amy Kruse is the Chief Scientific Officer of Optios, a San Diego-based applied neuroscience company that translates cutting-edge neuroscience discoveries into practical tools and programs that measurably enhance human performance. Before joining Optios, Dr. Kruse served as the Vice President and Chief Technology Officer of Cubic Global Defense, where she oversaw the company’s research and development programs.
Dr. Kruse also served as a government civilian program manager at the Defense Advanced Research Projects Agency (DARPA), where she created and oversaw the Agency’s first performance-oriented neuroscience program. Dr. Kruse is a frequent contributor to several defense panels and advisory boards for organizations including DARPA, the National Academies and the Defense Science Board. Her goal is to create a vibrant, widespread neurotechnology industry that allows humanity to upgrade the human brain and, thereby, the human condition.